On Wednesday August 14, 2024, Alpha Tau Medical Reported Q2 EPS $(0.11) Beats $(0.12) Estimate
On Wednesday August 14, 2024, Alpha Tau Medical Reported Q2 EPS $(0.11) Beats $(0.12) Estimate
2024年8月14日星期三，阿爾法陶醫療報告第二季度每股收益爲$(0.11)，超出預估$(0.12)
Alpha Tau Medical (NASDAQ:DRTS) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.12) by 8.33 percent. This is a 8.33 percent increase over losses of $(0.12) per share from the same period last year.
Alpha Tau Medical (納斯達克：DRTS)每股虧損$(0.11)，超過分析師預期的$(0.12)每股，增長8.33%。這比去年同期每股虧損$(0.12)增長了8.33%。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間